ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.

RLAY Relay Therapeutics Inc

8.13
1.05 (14.83%)
최종 업데이트: 22:32:47
15분 지연
기업명 주식 심볼 시장 주식 타입
Relay Therapeutics Inc RLAY 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
1.05 14.83% 8.13 22:32:47
개장가 저가 고가 종가 전일 종가
8.71 7.75 8.71 7.08
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
03/05/202405:05GLOBERelay Therapeutics Reports First Quarter 2024 Financial..
26/04/202405:05GLOBERelay Therapeutics to Announce First Quarter 2024 Financial..
12/04/202405:05GLOBERelay Therapeutics to Participate in Upcoming Investor..
27/02/202406:05GLOBERelay Therapeutics to Participate in Three Upcoming Investor..
23/02/202406:34EDGAR2Form S-8 - Securities to be offered to employees in employee..
23/02/202406:16EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
23/02/202406:10EDGAR2Form 8-K - Current report
23/02/202406:05GLOBERelay Therapeutics Reports Fourth Quarter and Full Year 2023..
16/02/202406:05GLOBERelay Therapeutics to Announce Fourth Quarter and Full Year..
02/02/202406:05GLOBERelay Therapeutics to Participate in the Guggenheim..
01/02/202406:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/02/202406:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/01/202406:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/01/202406:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/01/202406:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/01/202423:22EDGAR2Form 424B7 - Prospectus [Rule 424(b)(7)]
10/01/202423:14EDGAR2Form D - Notice of Exempt Offering of Securities
08/01/202421:05EDGAR2Form 8-K - Current report
08/01/202421:00GLOBERelay Therapeutics Announces $30 Million Private Placement..
03/01/202406:05GLOBERelay Therapeutics to Present at 42nd Annual J.P. Morgan..
30/12/202306:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/12/202306:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/11/202306:16EDGAR2Form 424B7 - Prospectus [Rule 424(b)(7)]
08/11/202306:05GLOBERelay Therapeutics to Participate in Stifel 2023 Healthcare..
03/11/202305:17EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03/11/202305:10EDGAR2Form 8-K - Current report
03/11/202305:05GLOBERelay Therapeutics Reports Third Quarter 2023 Financial..
02/11/202305:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/11/202305:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/10/202305:05GLOBERelay Therapeutics to Announce Third Quarter 2023 Financial..
13/10/202305:13EDGAR2Form 8-K - Current report
13/10/202305:05GLOBERelay Therapeutics Announces Initial RLY-4008..
30/09/202306:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/09/202305:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/09/202305:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/09/202305:05GLOBERelay Therapeutics to Present Clinical Data on RLY-4008 in..
09/08/202305:25EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/08/202305:14EDGAR2Form 8-K - Current report
09/08/202305:02GLOBERelay Therapeutics Reports Second Quarter 2023 Financial..
02/08/202305:05GLOBERelay Therapeutics to Announce Second Quarter 2023 Financial..
01/08/202305:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/08/202305:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/06/202306:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/06/202306:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/05/202306:01GLOBERelay Therapeutics Announces Full Dose Escalation Data for..
25/05/202305:05GLOBERelay Therapeutics to Participate in Two Upcoming Investor..
05/05/202305:05GLOBERelay Therapeutics Reports First Quarter 2023 Financial..

최근 히스토리

Delayed Upgrade Clock